Novozymes Balance Sheet Health
Financial Health criteria checks 4/6
Novozymes has a total shareholder equity of DKK14.4B and total debt of DKK7.4B, which brings its debt-to-equity ratio to 51.6%. Its total assets and total liabilities are DKK28.4B and DKK14.0B respectively. Novozymes's EBIT is DKK4.5B making its interest coverage ratio 53.8. It has cash and short-term investments of DKK1.1B.
Key information
51.6%
Debt to equity ratio
DKK 7.41b
Debt
Interest coverage ratio | 53.8x |
Cash | DKK 1.12b |
Equity | DKK 14.35b |
Total liabilities | DKK 14.04b |
Total assets | DKK 28.39b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NSIS N's short term assets (DKK9.5B) exceed its short term liabilities (DKK7.3B).
Long Term Liabilities: NSIS N's short term assets (DKK9.5B) exceed its long term liabilities (DKK6.8B).
Debt to Equity History and Analysis
Debt Level: NSIS N's net debt to equity ratio (43.9%) is considered high.
Reducing Debt: NSIS N's debt to equity ratio has increased from 28.5% to 51.6% over the past 5 years.
Debt Coverage: NSIS N's debt is well covered by operating cash flow (56%).
Interest Coverage: NSIS N's interest payments on its debt are well covered by EBIT (53.8x coverage).